You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Uduak Grace Thomas covers bioinformatics, computational biology, and life science informatics for GenomeWeb. Follow her on Twitter at @UduakGW.
The consortium will gather Nigerians' genomic, phenotypic, and clinical data in six geopolitical regions to study non-communicable and infectious diseases.
In addition to developing standards for proteomics, metabolomics, and other kinds of data, DNAnexus will develop tools to help reviewers quickly and easily assess analysis pipelines.
The company uses systems biology approaches and AI methods to model and analyze causal pathways in diseases including neurological cancers and Alzheimers.
The standards address ongoing data analysis issues including ways of securely sharing and analyzing genomic information across platforms and mechanisms for consistently identifying sequences.
Project partners will expand on infrastructure developed by DNAstack for accessing genomic data and explore patient consent models that support nationwide sharing.
Data from MMRF's Immune Atlas will be included in its recently launched CureCloud, a registry of clinical, genomic, and EHR data from multiple myeloma patients.
Metascape uses data from over 40 knowledgebases and 10 model organisms to provide functional enrichment, interactome analysis, gene annotation, and membership search capabilities.
DARTS uses deep learning-based techniques to leverage public RNA-sequencing datasets to make predictions about alternative splicing in individuals datasets.
The company shared details of its methods and results of some internal experiments but has been met with skepticism by members of the research community.
MSK's PathoMAN achieved 94 percent and 81 percent concordance with results from three commercial labs for pathogenic and benign variants, respectively.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.